Tech Company Financing Transactions

Magnolia Medical Technologies Funding Round

On 3/31/2017, Magnolia Medical Technologies raised $7.2 million in investment from private investors.

Transaction Overview

Announced On
3/31/2017
Transaction Type
Venture Equity
Amount
$7,249,997
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 33 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
200 W. Mercer St. 500
Seattle, WA 98119
USA
Email Address
Overview
Magnolia Medical Technologies has recently introduced the Initial Specimen Diversion Device (ISDD), a patented, Class I device registered and listed with FDA that is indicated to reduce the frequency of blood culture contamination.
Profile
Magnolia Medical Technologies LinkedIn Company Profile
Social Media
Magnolia Medical Technologies Company Twitter Account
Company News
Magnolia Medical Technologies News
Facebook
Magnolia Medical Technologies on Facebook
YouTube
Magnolia Medical Technologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gregory Bullington
  Gregory Bullington LinkedIn Profile  Gregory Bullington Twitter Account  Gregory Bullington News  Gregory Bullington on Facebook
Chief Medical Officer
Richard Patton
  Richard Patton LinkedIn Profile  Richard Patton Twitter Account  Richard Patton News  Richard Patton on Facebook
Chief Operating Officer
Robert Gerberich
  Robert Gerberich LinkedIn Profile  Robert Gerberich Twitter Account  Robert Gerberich News  Robert Gerberich on Facebook
VP - Sales
Matthew Stuckert
  Matthew Stuckert LinkedIn Profile  Matthew Stuckert Twitter Account  Matthew Stuckert News  Matthew Stuckert on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2017: Promentis Pharmaceuticals venture capital transaction
Next: 3/31/2017: Hazelcast venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary